PC端banner(4)(1)
10周年医疗英-111
about us
A Global Leading Supplier
of
In Vitro Diagnostic Solutions
Learn More
Heart and Cerebral Vessel Diseases
Quantum Dots Fluorescent Immune Solutions for
 
Cardiovascular Diseases
Learn More
covid-19 solutions
From sample to result
Molecular Test Solutions for
SARS-CoV-2 Nucleic Acid Detection
Reliable Operation
High Sensitivity
Efficient Method
Learn More
移动端banner(3)(1)
10周年banner3(1)
英网首页 banner 750 600
德国展会banner 750 600(2)
Products & Solutions
About Vazyme
About Vazyme
Science and Technology Make a Healthier Life​​​​​​​
Our Story
Together for a Better Future
Vazyme story

 Recent News

Vazyme goes public on Shanghai Stock Exchange today

Nanjing Vazyme Biotech Co.,;Ltd.(Vazyme)went public on the STAR MARKET of the Shanghai Stock Exchange under the stock code 688105.

Vazyme Releases 2021 Annual Report: Announces More Efforts in Technology innovation and Together with Partners for a Better Future

NANJING, China, June 1, 2022 /PRNewswire/ -- Vazyme, China's leading biotechnology company, has...

#BreakTheBias — Girls Can Do Whatever They Want To Do

#BreakTheBias — Girls Can Do Whatever They Want To Do

Subscribe to our Newsletter

Our vision is to lead in biotechnology by driving innovation relentlessly, pursuing the highest standards in quality of products and services, and creating value for our customers.

OUR PRODUCTS

MORE LINKS

CONTACT US

Address: Building D2, Hongfeng science and
Technology Park, Kechuang Road, Nanjing
Economic and Technological Development
Zone, Jiangsu Province, China
Tel:+86 400-969-0586
E-mail: service.medical@vazyme.com
Copyright @ 2022 Nanjing Vazyme Biotech Co.,Ltd. All Rights Reserved